Veritec (VRTC) News Today Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesSEC FilingsBuy This Stock VRTC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Scotiabank Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX)August 7, 2025 | theglobeandmail.comVertex Pharmaceuticals: Strong Growth and Strategic AdvancesAugust 7, 2025 | theglobeandmail.comStock Movers: Palantir, Caterpillar, Hims & Hers, VertexAugust 7, 2025 | bloomberg.comWells Fargo Upgrades Vertex Pharmaceuticals (VRTX)August 7, 2025 | msn.comVertex Pharmaceuticals (VRTX) Reports Strong Q2 2025 Revenue Growth with US$2,965 MillionAugust 7, 2025 | finance.yahoo.comVertex Pharmaceuticals Incorpor (VRTX) Stock forecastsAugust 6, 2025 | uk.finance.yahoo.comStock Movers: Vertex, Hims, Molson CoorsAugust 5, 2025 | bloomberg.comVertex Pharma plunges as trial setback overshadows Q2 beatAugust 5, 2025 | msn.comWhy Vertex Pharmaceuticals (VRTX) Stock Is Trading Lower TodayAugust 5, 2025 | msn.comVertex's trial failure, scrapped study cloud pain drug push; shares slumpAugust 5, 2025 | msn.comCRISPR falls after Q2 miss with Vertex-partnered gene therapy in focusAugust 5, 2025 | msn.comVertex Pharmaceuticals stock falls as pain drug fails in phase 2August 5, 2025 | msn.comVertex Pharmaceuticals’s (NASDAQ:VRTX) Q2 Sales Beat Estimates But Stock Drops 13.5%August 5, 2025 | finance.yahoo.comVertex Reports Second Quarter 2025 Financial ResultsAugust 4, 2025 | finance.yahoo.comVertex Stock Falls After Pain-Drug Setback, Despite Stronger EarningsAugust 4, 2025 | msn.comVertex Pharma posts strong Q2 results, but stock drops 8% as pain drug disappoints in Phase 2 studyAugust 4, 2025 | za.investing.comVertex to stop developing new painkiller as solo treatment after mid-stage study setbackAugust 4, 2025 | msn.comVertex Crashes After Pain Drug Flop Outweighs Second-Quarter BeatAugust 4, 2025 | msn.comVertex tops estimates on cystic fibrosis treatment strength, new productsAugust 4, 2025 | reuters.comWhat To Expect From Vertex Pharmaceuticals’s (VRTX) Q2 EarningsAugust 2, 2025 | finance.yahoo.comKBRA Assigns Preliminary Ratings to VRTX 2025-HQAugust 1, 2025 | finance.yahoo.comVertex says Health Canada grants Marketing Authorization for ALYFTREKJuly 22, 2025 | msn.comVertex Pharmaceuticals' Quarterly Earnings Preview: What You Need to KnowJuly 22, 2025 | msn.comVertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should KnowJuly 16, 2025 | msn.comVertex Pharmaceuticals (VRTX) Secures NHS England Agreement For Next-In-Class Cystic Fibrosis TreatmentJuly 15, 2025 | finance.yahoo.comEU Commission Approves Vertex Pharmaceutical’s (VRTX) Cystic Fibrosis TreatmentJuly 15, 2025 | finance.yahoo.comVertex to Announce Second Quarter 2025 Financial Results on August 4thJuly 8, 2025 | finance.yahoo.comVRTX - Vertex Pharmaceuticals Inc Chart - MorningstarJuly 8, 2025 | morningstar.comMVertex Protocol Team to Join Ink Foundation, Build New DeFi Primitives on Ink Layer-2July 8, 2025 | finance.yahoo.comVRTX - Vertex Pharmaceuticals Inc Valuation - MorningstarJuly 5, 2025 | morningstar.comMVertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EUJuly 1, 2025 | msn.com$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much TodayJune 30, 2025 | benzinga.comVRTX - Vertex Pharmaceuticals Inc Ownership - MorningstarJune 26, 2025 | morningstar.comMVRTX - Vertex Pharmaceuticals Inc Sustainability - MorningstarJune 26, 2025 | morningstar.comMVeritec, Inc. (VRTC) stock price, news, quote & history - Yahoo FinanceJune 26, 2025 | au.finance.yahoo.comVertex posts additional trial data for type 1 diabetes therapyJune 21, 2025 | msn.comVertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific SessionsJune 20, 2025 | finance.yahoo.comVertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek UptakeJune 20, 2025 | insidermonkey.comA Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 AnalystsJune 17, 2025 | benzinga.comCrispr Therapeutics: Early-Stage Research Updates Show PromiseJune 11, 2025 | seekingalpha.comVertex Pharmaceuticals Inc. CEDEARJune 11, 2025 | barrons.comVertex Pharmaceuticals (NasdaqGS:VRTX) Highlights Clinical Benefits Of ALYFTREK At Cystic Fibrosis ConferenceJune 7, 2025 | finance.yahoo.com3 No-Brainer Healthcare Stocks to Buy in JuneJune 2, 2025 | msn.comVertex misses on both lines in Q1 as 2025 revenue forecast narrowedMay 5, 2025 | msn.comVertex Pharmaceuticals misses Q1 estimates, shares slipMay 5, 2025 | in.investing.comVertex misses quarterly results on weaker-than-expected sales for cystic fibrosis drugMay 5, 2025 | msn.comVertex Pharmaceuticals (NASDAQ:VRTX) Reports Sales Below Analyst Estimates In Q1 EarningsMay 5, 2025 | finance.yahoo.comEarnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results TomorrowMay 5, 2025 | msn.comVertex Pharmaceuticals’ Q1 2025 Earnings: What to ExpectApril 23, 2025 | msn.comVertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should KnowApril 10, 2025 | msn.com Get Veritec News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTC Media Mentions By Week VRTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTC News Sentiment▼-0.170.63▲Average Computer and Technology News Sentiment VRTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTC Articles This Week▼193▲VRTC Articles Average Week Get Veritec News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Acuren News Advantage Solutions News Alta Global Group News Altitude International News American Heritage International News Arcadis News Auddia News Baosheng Media Group News Beyond Commerce News bioAffinity Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VRTC) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veritec Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veritec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale